Proteostasis Landscapes of Cystic Fibrosis Variants Reveals Drug Response Vulnerability
E. F. McDonald, M. Kim, J. A. Olson, J. Meiler, L. Plate
The paper uses proteomics and computational modeling to analyze CFTR variants, identifying structural vulnerabilities in NBD1 that limit corrector efficacy and suggesting secondary mutations as a therapeutic strategy.
bioRxiv · Jul 10, 2024Biochemistry